STRATFORD, Conn.

康涅狄格州斯特拉特福德

,

，

June 4, 2026

/PRNewswire/ -- ALS United Connecticut is accelerating progress in ALS research through continued investment and deepened national collaboration, reinforcing a shared commitment to advancing treatment, prevention, and understanding of the disease.

/美通社/ -- 康涅狄格州ALS联合组织通过持续投资和深化全国合作，加速肌萎缩侧索硬化症（ALS）研究的进展，进一步强化了在推进该疾病治疗、预防和认知方面的共同承诺。

ALS United Connecticut, in partnership with the ALS Network, is proud to announce a second year of research funding for the Biotech company AUTTX, recognizing the company's exceptional scientific progress and promising early results during its initial funding period. This follow-on investment reflects the organizations' shared commitment to advancing bold, translational science with the potential to deliver meaningful new therapies for people living with amyotrophic lateral sclerosis (ALS)..

康涅狄格州ALS联合组织与ALS网络合作，自豪地宣布为生物技术公司AUTTX提供第二年的研究资助，以表彰该公司在初始资助期间取得的卓越科学进展和令人鼓舞的早期成果。这项后续投资体现了各组织共同致力于推进具有转化潜力的前沿科学研究，旨在为肌萎缩侧索硬化症（ALS）患者带来有意义的新疗法。

'Transformative progress in ALS research only happens when urgency is matched with action,' said Jacky Rose, Executive Director at ALS United Connecticut. 'Through collaboration, innovation, and sustained investment in promising science, we are helping pave the way toward meaningful advances for people and families affected by ALS.'.

“只有将紧迫感转化为实际行动，肌萎缩侧索硬化症（ALS）研究才能取得变革性进展。”康涅狄格州ALS联合协会执行董事杰基·罗斯表示，“通过协作、创新以及对有前景的科学研究进行持续投入，我们正帮助为受ALS影响的个人和家庭铺就通往实质性进步的道路。”

ALS United Connecticut's funding supports the work of AUTTX to advance the development of new molecules that aim to restore normal RNA processing in people with ALS, potentially leading to new treatments for ALS.

康涅狄格州ALS联合会的资助支持AUTTX的工作，以推进旨在恢复肌萎缩侧索硬化症（ALS）患者正常RNA处理的新分子的开发，从而可能为ALS带来新的治疗方法。

The research will be led by AUTTX's co-founders Isabelle Draper, PhD, who serves as the company's chief scientific officer, and Alan S. Kopin, MD, its CEO. Draper leads a laboratory at Tufts Medical Center and is focused on studying alterations in RNA processing in animal models. Kopin, a professor emeritus at Tufts University School of Medicine, has been involved in research examining the abnormal processing of the Stathmin-2 protein due to TDP-43 dysfunction..

本研究将由AUTTX的联合创始人伊莎贝尔·德雷珀（Isabelle Draper）博士和艾伦·S·科平（Alan S. Kopin）医学博士共同领导。德雷珀博士担任公司首席科学官，在塔夫茨医疗中心领导一个实验室，专注于研究动物模型中RNA加工的变异。科平博士是公司首席执行官，也是塔夫茨大学医学院的名誉教授，其研究工作涉及因TDP-43功能障碍导致的Stathmin-2蛋白异常加工。

Through strategic funding and partnership, ALS United Connecticut is helping sustain momentum and ensure promising discoveries to move forward.

通过战略性资金支持和伙伴关系，ALS United Connecticut 正在帮助维持发展势头，并确保有前景的发现得以持续推进。

The first year of funding was provided by ALS United and the ALS Network through a collaborative Innovation Research Grant program. That program, facilitated by ALS Network, maximizes impact by streamlining infrastructure, reducing duplication, and directing more resources toward high-potential research..

首年的资金由美国肌萎缩侧索硬化症联合协会（ALS United）和肌萎缩侧索硬化症网络（ALS Network）通过一项合作创新研究资助计划提供。该计划由肌萎缩侧索硬化症网络协调，通过简化基础设施、减少重复工作并将更多资源导向高潜力研究，从而最大化其影响力。

'AUTTX  demonstrated exceptional momentum, scientific rigor, and compelling proof-of-concept data during the first year of this award,' said Sheri Strahl, President and CEO of ALS Network. 'We are thrilled to continue supporting this work alongside ALS United Connecticut as the team advances promising molecules toward the next stage of development.

“AUTTX 在本奖项的第一年展现了卓越的进展势头、严谨的科学态度以及令人信服的 концептуаль验证数据，”ALS Network 总裁兼首席执行官 Sheri Strahl 表示。“我们很高兴能与 ALS United Connecticut 继续支持这项工作，伴随团队将有前景的分子推进至下一开发阶段。”

This is exactly the type of high-risk, high-reward translational science our organizations are committed to championing.'.

这正是我们组织致力于倡导的高风险、高回报的转化科学类型。

Together, these efforts reflect a shared commitment to advancing research, strengthening care, and driving advocacy, ensuring continued progress and hope for people living with ALS and their loved ones.

这些共同努力体现了我们在推进研究、加强护理和推动倡导方面的共同承诺，确保为肌萎缩侧索硬化症（ALS）患者及其亲人带来持续的进展和希望。

Learn more at

了解更多，请访问

https://alsunitedct.org/research/our-approach/

https://alsunitedct.org/research/our-approach/

.

。

Media Contact: Paul Silverfarb,

媒体联系人：保罗·西尔弗法布，

[email protected]

[email protected]

SOURCE ALS United

来源：美国肌萎缩侧索硬化症协会

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示